Skip to main content
    L

    LAVA Therapeutics NV (LVTX)

    Official site

    BIOTECHNOLOGY

    $1.74
    +0.00 (+0.00%)

    Last updated: Dec 05, 2025 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(10/19)
    Avg Surprise
    -57.11%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 26
    		$-0.27$-0.24-10.20%Miss+37.9%
    Jun 25
    Reported Aug 13
    		$-0.32$-0.30-6.67%Miss-3.2%
    Mar 25
    Reported May 19
    		$-0.12N/A+68.92%Beat-482.0%
    Dec 24
    Reported Mar 18
    		$-0.13N/A+51.33%Beat+46.0%
    Sep 24
    Reported Nov 14
    		$-0.43$-0.32-34.20%Miss-27.9%
    Jun 24
    Reported Aug 20
    		$-0.31$-0.36+13.89%Beat+35.4%
    Mar 24
    Reported May 21
    		$-0.02N/A+83.33%Beat+96.2%
    Dec 23
    Reported Mar 20
    		$-0.24$-0.12-100.00%Miss+66.7%
    Sep 23
    Reported Nov 16
    		$-0.34$-0.49+30.61%Beat-950.0%
    Jun 23
    Reported Aug 22
    		$-0.48$-0.47-2.13%Miss-65.5%
    Mar 23
    Reported Jun 8
    		$-0.53$-0.52-1.92%Miss-43.2%
    Dec 22
    Reported Mar 24
    		$-0.72$-0.61-18.03%Miss-118.2%
    Sep 22
    Reported Nov 16
    		$0.04N/A+130.77%Beat+114.8%
    Jun 22
    Reported Sep 13
    		$-0.29N/A+51.67%Beat-3.6%
    Mar 22
    Reported May 17
    		$-0.37N/A+54.88%Beat+97.0%
    Dec 21
    Reported Mar 24
    		$-0.33$-0.36+8.33%Beat-
    Sep 21
    Reported Nov 15
    		$-0.27$-0.31+12.90%Beat-
    Jun 21
    Reported Aug 16
    		$-0.28$-0.27-3.70%Miss-
    Mar 21
    Reported May 20
    		$-12.27$-0.81-1414.81%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.74
    SMA 20$1.71
    SMA 50$1.63
    SMA 200N/A
    EMA 10$1.73
    EMA 20$1.71
    EMA 50$1.65
    EMA 200$1.46

    MACD

    Line: 0.04Signal: 0.04Hist: -0.00

    ADX

    ADX: 18.5+DI: 26.0-DI: 19.8

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down36.0
    PSAR$1.68

    Bollinger Bands

    Upper Band$1.83
    Lower Band$1.58
    %B Position1452%(Upper)
    Band Width0.63

    RSI (14-Day)

    Neutral
    62.2

    Momentum Oscillators

    Stoch %K62.2
    Stoch %D63.2
    Williams %R-37.8
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)47.1
    MFI (14d)70.5

    Volatility Measures

    ATR (14d)$0.03(2.0%)
    StdDev (20d)0.06
    Hist Vol39.2%(Moderate)

    Volume Flow

    VWAP$1.74
    OBV3.8M
    AD Line7.2M
    CMF (20d)0.498

    Volume Metrics

    Avg Vol (20d)104.8K
    Vol RatioN/A
    VWMA (20d)$1.72

    Pivot Points

    R3$1.74
    R2$1.74
    R1$1.74
    Pivot Point$1.74
    S1$1.74
    S2$1.74
    S3$1.74

    Advanced Oscillators

    TSI25.37
    Ultimate OscN/A
    KST88.33

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$0$0$0$4.99M$0$0$6.99M$353,000$53,000$5.14M$1.22M$2.64M
    Cost of Revenue$0$0$0$24.55M$0$0$0$154,000$10,000$2.39M$930,000N/A
    Gross Profit$0$0$0$-19,560,000$0$0$6.99M$199,000$43,000$2.75M$294,000$2.64M
    Operating Expenses$7.55M$7.29M$7.59M$-12,464,000$11.34M$9.39M$9.03M$5.64M$10.77M$16.30M$13.83M$14.20M
    R&D$2.24M$4.74M$4.16M$7.61M$8.28M$5.96M$5.65M$3.36M$7.91M$12.60M$9.94M$10.49M
    SG&A$5.31M$2.55M$3.43M$4.48M$3.06M$3.44M$3.38M$2.28M$2.86M$3.70M$3.89M$3.71M
    Operating Income$-7,553,000$-7,289,000$-7,588,000$-7,096,000$-11,340,000$-9,393,000$-2,036,000$-5,442,000$-10,727,000$-13,545,000$-13,539,000$-11,560,000
    Interest Income$537,000$607,000$713,000$1.33M$957,000$968,000$970,000$0$809,000$698,000$617,000$0
    Interest Expense$0$0$-5,074,000$515,000$131,000$129,000$130,000$995,000$0$0$10.47M$10.47M
    Income Before Tax$-7,182,000$-8,567,000$-3,254,000$-3,590,000$-12,233,000$-8,214,000$-539,000$-6,437,000$-8,786,000$-12,603,000$-13,869,000$-14,929,000
    Income Tax Expense$6,000$72,000$225,000$380,000$96,000$86,000$69,000$61,000$50,000$97,000$71,000$67,000
    Net Income$-7,188,000$-8,639,000$-3,479,000$-3,970,000$-12,329,000$-8,300,000$-608,000$-6,498,000$-8,836,000$-12,700,000$-13,940,000$-14,996,000
    EBITDA$-6,609,000$-9,710,000$-9,497,000$-3,109,000$-13,636,000$-9,600,000$-1,910,000$-3,300,000$-10,409,000$-13,250,000$-13,226,000$-4,187,000
    EBIT$-7,719,000$-9,174,000$-9,041,000$-3,196,000$-13,059,000$-9,053,000$-1,379,000$-3,652,000$-10,727,000$-13,545,000$-13,539,000$-11,560,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LVTX

    News

    No news available

    Company news will appear here when available

    LVTX Competitors

    CompanyTicker
    Hyperion DeFi, Inc.HYPD
    Celularity IncCELU
    ImageneBio, Inc.IMA
    Xtant Medical Holdings IncXTNT
    Sensus Healthcare IncSRTS
    INmune Bio IncINMB
    Werewolf Therapeutics IncHOWL
    Serina Therapeutics IncSER

    Sector: Healthcare

    LVTX Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    8.3%

    Frequently Asked Questions About LVTX

    Does LVTX pay dividends?

    LAVA Therapeutics NV (LVTX) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In